Japan Archives -

A Japanese language version of Akili Interactive’s EndeavorRx ground-breaking digital therapy for attention deficit hyperactivity disorder (ADHD) has

Shionogi starts pivotal Japanese trial of Akili’s ADHD app

https://pharmaphorum.com/news/shionogi-starts-pivotal-japanese-trial-of-akilis-adhd-app/

News/ News/ R&D

Daiichi makes play for share of Japan’s COVID booster market

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, Daiichi Sankyo, Japan, Omicron 0 Comment

Daiichi Sankyo has stepped up its efforts to bring a Japanese COVID-19 vaccine to patients, starting a new

Daiichi makes play for share of Japan’s COVID booster market

https://pharmaphorum.com/news/daiichi-makes-play-for-share-of-japans-covid-booster-market/

Market Access/ News/ News

Japan looks set to follow EU in rejecting Alzheimer’s drug Aduhelm

Phil Taylor Aduhelm, Biogen, Eisai, Japan, regulatory 0 Comment

The Japanese regulator looks like it could follow the European Commission and reject approval of Biogen and Eisai’s

Japan looks set to follow EU in rejecting Alzheimer’s drug Aduhelm

https://pharmaphorum.com/news/japan-looks-set-to-follow-eu-in-rejecting-alzheimers-drug-aduhelm/

News/ News/ Oncology

First launch for Daiichi Sankyo’s oncolytic virus Delytact in Japan

Phil Taylor brain cancer, Daiichi Sankyo, Delytact, immuno-oncology, Japan, Oncology, oncolytic virus, regulatory approval 0 Comment

Daiichi Sankyo has launched its oncolytic virus therapy Delytact in Japan – its first world market – as

First launch for Daiichi Sankyo’s oncolytic virus Delytact in Japan

https://pharmaphorum.com/news/first-launch-for-daiichi-sankyos-oncolytic-virus-delytact-in-japan/

Deep Dive/ Sales and Marketing/ Views & Analysis/ Views and analysis

BMS’ Catherine Owen: Hybrid communication is here to stay

mike.hammerton@pharmaphorum.com Bristol-Myers Squibb, Canada, Catherine Owen, Communications and Commercialisation, Deep Dive, Deep Dive: Communications and Commercialisation, Dominic Tyer, Europe, Japan 0 Comment

The company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of

BMS’ Catherine Owen: Hybrid communication is here to stay

https://pharmaphorum.com/sales-marketing/bms-catherine-owen-hybrid-communication-is-here-to-stay/

Market Access/ News/ News

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

Phil Taylor Alofisel, cell therapy, Crohn's disease, Japan, regulatory approval, Takeda 0 Comment

Takeda has chalked up another milestone for its Alofisel cell therapy for a complication of Crohn’s disease, becoming

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

https://pharmaphorum.com/news/takeda-bags-japanese-approval-for-crohns-cell-therapy-alofisel/

News/ News/ Oncology

Daiichi Sankyo claims first okay for oncolytic virus in Japan

Phil Taylor Daiichi Sankyo, Delytact, glioblastoma, immuno-oncology, Japan, Oncology, oncolytic virus 0 Comment

Daiichi Sankyo has made a little bit of pharma industry history, becoming the first drugmaker to win approval

Daiichi Sankyo claims first okay for oncolytic virus in Japan

https://pharmaphorum.com/news/daiichi-sankyo-claims-first-okay-for-cancer-killing-virus-in-japan/

News/ News/ R&D

Novo Nordisk crowns cell therapy pipeline with $598m Heartseed deal

Phil Taylor cardiology, heart failure, Heartseed, Japan, Novo Nordisk, Regenerative medicine, stem cell therapy 0 Comment

Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed

Novo Nordisk crowns cell therapy pipeline with $598m Heartseed deal

https://pharmaphorum.com/news/novo-nordisk-crowns-cell-therapy-pipeline-with-598m-heartseed-deal/

Market Access/ News/ News

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Phil Taylor Belsomra, Dayvigo, Eisai, insomnia, Japan, Merck & Co 0 Comment

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

https://pharmaphorum.com/news/chasing-merck-eisai-launches-insomnia-drug-dayvigo-in-japan/

Trending

Japan

Login